Increased levels of annexin A1 have been reported in acute idiopathic pulmonary fibrosis and liver fibrosis [21], while in COPD it promotes lung fibroblast proliferation, migration, and differentiation through ERK1/2 and p38 signalling [22]. This evidence concerns the gene MAPK3 and Hepatic fibrosis.